EUROPA substudies, confirmation of pathophysiological concepts. European trial on reduction of cardiac events with perindopril in stable coronary artery disease.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 9796842)

Published in Eur Heart J on September 01, 1998

Authors

M L Simoons1, J Vos, P J de Feyter, M L Bots, W J Remme, D E Grobbee, C Kluft, M P de Maat, K M Fox, J W Deckers

Author Affiliations

1: Thoraxcenter, University Hospital Rotterdam, The Netherlands.

Articles citing this

Role of bradykinin and eNOS in the anti-ischaemic effect of trandolapril. Br J Pharmacol (2001) 0.78

Articles by these authors

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med (1999) 29.32

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet (2007) 14.96

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med (1995) 13.01

Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet (1996) 8.50

Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol (1991) 7.67

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 7.03

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ (2009) 5.14

Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med (1995) 5.12

The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet (1997) 5.04

Cardiovascular mortality in Dutch men during 1996 European football championship: longitudinal population study. BMJ (2001) 4.87

The epidemiology of heart failure. Eur Heart J (1997) 4.31

Recovery from hip fracture in eight areas of function. J Gerontol A Biol Sci Med Sci (2000) 4.19

Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke (2001) 3.99

Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study. Circulation (2001) 3.96

J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet (1994) 3.95

Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75

Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation (2000) 3.61

J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension (1999) 3.51

External validation is necessary in prediction research: a clinical example. J Clin Epidemiol (2003) 3.49

Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ (1995) 3.42

Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol (1998) 3.37

The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology (1994) 3.30

Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J (1999) 3.18

Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet (1985) 3.13

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. Eur Heart J (2000) 3.07

The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J (2001) 3.07

Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation (2005) 2.99

Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia (1997) 2.82

Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82

Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol (1996) 2.80

Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke (1997) 2.79

Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med (1995) 2.70

Excess mortality attributable to hip fracture in white women aged 70 years and older. Am J Public Health (1997) 2.68

Coronary angiography with multi-slice computed tomography. Lancet (2001) 2.64

Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ (1994) 2.60

Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol (1986) 2.58

Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53

Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke (2001) 2.49

A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab (1998) 2.45

Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol (1996) 2.45

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ (2001) 2.43

Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology (1995) 2.43

Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension. J Hypertens (1995) 2.40

The economic cost of hip fractures in community-dwelling older adults: a prospective study. J Am Geriatr Soc (1997) 2.40

Self-reported prevalence and awareness of metabolic syndrome: findings from SHIELD. Int J Clin Pract (2008) 2.39

Plasminogen activator inhibitors. Blood (1987) 2.38

The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol (1994) 2.38

Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab (2000) 2.36

Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med (2001) 2.35

Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke (2003) 2.31

Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology (1995) 2.30

Limitations of sensitivity, specificity, likelihood ratio, and bayes' theorem in assessing diagnostic probabilities: a clinical example. Epidemiology (1997) 2.28

Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands. J Am Coll Cardiol (1989) 2.23

Carotid intima-media thickness at different sites: relation to incident myocardial infarction; The Rotterdam Study. Eur Heart J (2002) 2.22

A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost (1982) 2.22

Costs and effects of long-term oral anticoagulant treatment after myocardial infarction. JAMA (1995) 2.20

Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2003) 2.18

QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation (1998) 2.15

Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke (1994) 2.14

Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators. Lancet (1990) 2.12

Proxy reporting in five areas of functional status. Comparison with self-reports and observations of performance. Am J Epidemiol (1997) 2.11

Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med (1994) 2.11

Preoperative prediction of severe postoperative pain. Pain (2003) 2.11

Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993. Heart (1996) 2.10

Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study. Eur Heart J (1999) 2.09

Low testosterone concentrations and the symptoms of testosterone deficiency according to the Androgen Deficiency in Ageing Males (ADAM) and Ageing Males' Symptoms rating scale (AMS) questionnaires. Clin Endocrinol (Oxf) (2011) 2.09

Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT) Lancet (2000) 2.08

Associations of radiological osteoarthritis of the hip and knee with locomotor disability in the Rotterdam Study. Ann Rheum Dis (1998) 2.08

Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J (1982) 2.07

Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. Eur Heart J (2002) 2.06

Distribution of central corneal thickness and its association with intraocular pressure: The Rotterdam Study. Am J Ophthalmol (1997) 2.04

[Nutrition and health--hypertension]. Ned Tijdschr Geneeskd (2003) 2.04

[Short preoperative health assessment proposed by the Health Council not useful in clinical practice]. Ned Tijdschr Geneeskd (2001) 2.04

Stent implantation reduces restenosis in patients with suboptimal results following coronary angioplasty. Eur Heart J (1999) 2.04

Carotid artery intima-media thickness as an indicator of generalized atherosclerosis. J Intern Med (1994) 2.03

Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol (1995) 2.02

Updating methods improved the performance of a clinical prediction model in new patients. J Clin Epidemiol (2007) 2.01

Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies; single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction. Eur Heart J (2002) 1.99

Economic aspects of treatment with captopril for patients with asymptomatic left ventricular dysfunction in The Netherlands. Eur Heart J (1996) 1.98

Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med (1998) 1.97

Application of treatment thresholds to diagnostic-test evaluation: an alternative to the comparison of areas under receiver operating characteristic curves. Med Decis Making (1997) 1.96

Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens (2003) 1.96

Atherosclerotic coronary lesions with inadequate compensatory enlargement have smaller plaque and vessel volumes: observations with three dimensional intravascular ultrasound in vivo. Heart (1998) 1.87

Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J (2001) 1.85

Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. BMJ (1994) 1.83